Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.
Open Access
- 1 October 1994
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (43) , 26801-26805
- https://doi.org/10.1016/s0021-9258(18)47090-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.Proceedings of the National Academy of Sciences, 1993
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Current concepts in antisense drug designJournal of Medicinal Chemistry, 1993
- Human therapeutics based on triple helix technologyTrends in Biotechnology, 1992
- Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κBScience, 1992
- Characterization of nuclear protein binding to the interferon‐γ promoter in quiescent and activated human T cellsEuropean Journal of Immunology, 1992
- Oligonucleotide-based therapeuticsNature, 1991
- Interaction of the v-rel protein with an NF-kappa B DNA binding site.Proceedings of the National Academy of Sciences, 1991
- Regulation of Gene Expression with Double-Stranded Phosphorothioate OligonucleotidesScience, 1990
- Inhibition in vitro transcription by specific double-stranded oligodeoxyribonucleotidesGene, 1990